LY-3022855 | m-entrepreneurship.com

Product Name :
LY-3022855

Search keywords :
LY3022855

drugId :
null

Target Vo:
Colony stimulating factor 1 receptor

Target Vo Short Name :
CSF1R

Moa_Name:
Colony stimulating factor 1 receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Eli Lilly And Company

Active Company_Name :
Dana-Farber Cancer Institute

Active Indication_Name:
Melanoma

In Active Indication_Name:
Solid tumours

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
E2F1 Antibody
CDK16 Antibody
Carbonic anhydrase 9 Antibody: Carbonic anhydrase 9 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 50 kDa, targeting to Carbonic anhydrase 9. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts